Benign prostatic hyperplasia (BPH) is one of the most common urologic conditions affecting men as they age, with nearly 50% of men over 50 experiencing symptoms. Despite its prevalence, treatment ...

Firstly, samples from different platforms are difficult to compare and secondly, it is not currently possible to evaluate a single sample against previously generated data from other patients. EMBER ...

SAN FRANCISCO — Patients who begin biologic treatment for severe asthma have fewer new-onset adverse outcomes than those who do not begin biologics, according to a poster presented at the ...

Best-in-disease profile with JAK-like efficacy and monthly (Q4W) dosing in both three-month placebo-controlled and six-month​ blinded treatment period Favorable safety and tolerability, particularly ...

Objective Individual patients with the same condition may respond differently to similar treatments. Our aim is to summarise the reporting of person-level heterogeneity of treatment effects (HTE) in ...

When used strategically, real-world data can shift care upstream, from hospitals to patients and communities, and from crisis ...

While data privacy makes attribution more challenging than ever, it’s a welcome challenge for those who value its intentions.

Increasingly, universities are collecting and analyzing student data for a variety of purposes. At the University of Arizona, for example, a researcher analyzed the swipes of student ID cards at ...

SAN DIEGO - Fate Therapeutics Inc. (NASDAQ: FATE), a biopharmaceutical company currently valued at approximately $140 million, announced today that it will present clinical and preclinical data ...

Aston University biostatistician Dr. Dan Green has identified the top ten errors he commonly sees in research papers in his ...